Skip to content
Clinical Trials – home

PHLEUM PRATENSE: A Comprehensive Guide for Patients

1 / 3
trials open to patients / all trials
7+
Countries

In short

This article summarizes several clinical trials investigating the use of Phleum pratense (Timothy grass) extracts for treating allergic rhinitis. These trials explore different administration methods, dosing regimens, and combinations with other therapies to evaluate the efficacy and safety of Phleum pratense immunotherapy for grass pollen allergies.

At a glance

Treatment Types
Subcutaneous injections (SCIT), Sublingual tablets (SLIT), Intralymphatic injections
Main Allergen
Phleum pratense (Timothy grass) pollen extract
Primary Outcomes
Symptom scores, Medication use, Combined symptom and medication scores (cSMS)
Secondary Outcomes
Antibody levels (IgE, IgG4), Basophil activation, Nasal airflow, Quality of life measures
Treatment Durations
Varied from 60 days to multiple years
Safety Monitoring
Local and systemic reactions, Adverse events
Novel Approaches
Intralymphatic injections, Combination with probiotics
Study Designs
Randomized, double-blind, placebo-controlled trials; some with environmental challenge chambers

What is Phleum Pratense?

Phleum pratense, also known as Timothy grass pollen extract, is a type of allergen extract used in immunotherapy for grass pollen allergies. It's derived from Timothy grass, a common cause of hay fever. This extract is used to help your body build tolerance to grass pollen, reducing allergic reactions over time.

You might see Phleum pratense referred to by different names in medical settings or on medication labels. Some common synonyms include:

  • AVANZ Phleum pratense
  • SQ Grass SLIT-tablet
  • GRAZAX/GRASTEK

Conditions Treated

Phleum pratense is primarily used to treat allergic conditions related to grass pollen, including:

  • Allergic rhinoconjunctivitis: This condition involves inflammation of the nose and eyes due to an allergic reaction. Symptoms may include sneezing, runny nose, itchy eyes, and nasal congestion.
  • Seasonal allergic rhinitis: Also known as hay fever, this condition causes allergy symptoms during specific seasons when certain plants pollinate.
  • Grass pollen-induced allergic rhinitis: This is a specific type of seasonal allergic rhinitis caused by grass pollen.

Administration Methods

Phleum pratense can be administered in several ways:

  • Subcutaneous immunotherapy (SCIT): This involves injections under the skin, typically given in a doctor's office.
  • Sublingual immunotherapy (SLIT): This method uses tablets or drops placed under the tongue, which can often be taken at home.
  • Intralymphatic immunotherapy (ILIT): This is a newer method where the allergen is injected directly into lymph nodes. It's still being researched and may not be widely available.

The treatment usually involves an initial phase with increasing doses, followed by a maintenance phase. The exact schedule can vary depending on the specific product and administration method.

Effectiveness

Studies have shown that Phleum pratense immunotherapy can be effective in reducing allergy symptoms and the need for medication. For example:

  • Sublingual tablets have been shown to reduce symptom scores by about 30% and seasonal rescue medication use by about 38% compared to placebo.
  • The effects of the treatment can persist for several years after the treatment is stopped.

Effectiveness is often measured using a combined symptom and medication score (cSMS), which takes into account both the severity of symptoms and the amount of medication needed to control them.

Side Effects and Safety

Phleum pratense immunotherapy is generally well-tolerated, but like all medical treatments, it can have side effects. These may include:

  • Local reactions at the injection or application site
  • Mild systemic reactions such as itching or mild allergy symptoms

In rare cases, more severe allergic reactions can occur. That's why the initial doses are usually given under medical supervision.

The safety profile of sublingual tablets (SLIT) appears to be better than that of subcutaneous injections (SCIT), with a lower risk of severe reactions.

Ongoing Research

Research on Phleum pratense immunotherapy is ongoing. Some areas of current investigation include:

  • Comparing different administration methods (subcutaneous, sublingual, and intralymphatic) to determine which is most effective and has the best safety profile.
  • Studying the immunological changes that occur during treatment, such as changes in antibody levels and immune cell responses.
  • Investigating the potential of combining immunotherapy with other treatments, such as probiotics.

These ongoing studies aim to improve the effectiveness of Phleum pratense immunotherapy and potentially expand its uses in treating allergic conditions.

Questions people often ask

Conditions where Phleum Pratense is being studied

Each condition opens its own overview and trial list

Trials with Phleum Pratense

Recruiting trials first

See all 3 →
Quick filters
  • Participants:All ages
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.